Stock Events

Medpace 

M$6,890
116
+M$0+0% Friday 15:19

Statistiche

In rialzo oggi
-
In ribasso oggi
-
In rialzo da 52 settimane
-
In ribasso da 52 settimane
-
Volume
-
Volume medio
-
Cap. di mercato
133.17B
Rapporto P/E
33.63
Rendimento da dividendi
-
Dividendo
-

Prossimamente

Guadagni

21OctAtteso
Q1 2024
Q2 2024
Avanti
42.22
46.62
51.02
55.42
EPS attesi
55.4189644851
EPS effettivi
N/D

Le persone seguono anche

Questo elenco si basa sulle watchlist delle persone su Stock Events che seguono MEDP.MX. Non rappresenta una raccomandazione d'investimento.

Concorrenti

Questo elenco è un'analisi basata su recenti eventi di mercato. Non è una raccomandazione di investimento.

Info

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
Show more...
CEO
Dr. August James Troendle M.D.
Dipendenti
5000
Paese
United States
ISIN
US58506Q1094

Quotazioni